pI: 6.7007 |
Length (AA): 414 |
MW (Da): 45367 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
26 | 296 | 3b1b (A) | 24 | 371 | 24.00 | 0 | 1 | 0.828189 | 0.21 |
28 | 299 | 4twl (A) | 3 | 236 | 21.00 | 0 | 1 | 0.806305 | -0.07 |
62 | 273 | 3q31 (A) | 45 | 246 | 28.00 | 0.000000000026 | 1 | 0.772577 | -0.2 |
233 | 298 | 3jxg (A) | 248 | 319 | 41.00 | 0.0012 | 0.4 | 0.40592 | 1.04 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127628)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G52720 | alpha carbonic anhydrase 1 |
Arabidopsis thaliana | AT1G08080 | alpha carbonic anhydrase 7 |
Brugia malayi | Bm1_34100 | Eukaryotic-type carbonic anhydrase family protein |
Brugia malayi | Bm1_32535 | Putative carbonic anhydrase 5 precursor |
Caenorhabditis elegans | CELE_K05G3.3 | Protein CAH-3 |
Drosophila melanogaster | Dmel_CG6906 | Carbonic anhydrase 2 |
Drosophila melanogaster | Dmel_CG18672 | CG18672 gene product from transcript CG18672-RC |
Echinococcus granulosus | EgrG_000535400 | carbonic anhydrase II |
Echinococcus multilocularis | EmuJ_000535400 | carbonic anhydrase II |
Homo sapiens | ENSG00000168748 | carbonic anhydrase VII |
Homo sapiens | ENSG00000104267 | carbonic anhydrase II |
Leishmania braziliensis | LbrM.28.0490 | carbonic anhydrase-like protein |
Leishmania donovani | LdBPK_280280.1 | carbonic anhydrase-like protein |
Leishmania infantum | LinJ.28.0280 | carbonic anhydrase-like protein |
Leishmania major | LmjF.28.0480 | carbonic anhydrase-like protein |
Leishmania mexicana | LmxM.28.0480 | carbonic anhydrase-like protein |
Loa Loa (eye worm) | LOAG_03324 | eukaryotic-type carbonic anhydrase |
Loa Loa (eye worm) | LOAG_08956 | carbonic anhydrase 3 |
Mus musculus | ENSMUSG00000027562 | carbonic anhydrase 2 |
Mus musculus | ENSMUSG00000031883 | carbonic anhydrase 7 |
Oryza sativa | 4329556 | Os02g0533300 |
Oryza sativa | 4349804 | Os11g0153200 |
Oryza sativa | 4351529 | Os12g0153500 |
Schistosoma japonicum | Sjp_0304090 | ko:K01672 carbonic anhydrase [EC4.2.1.1], putative |
Schistosoma mansoni | Smp_028670.2 | carbonic anhydrase II (carbonate dehydratase II) |
Schistosoma mansoni | Smp_028670.1 | carbonic anhydrase II (carbonate dehydratase II) |
Schmidtea mediterranea | mk4.029768.00 | Carbonic anhydrase-related protein |
Schmidtea mediterranea | mk4.000533.07 | Carbonic anhydrase-related protein |
Schmidtea mediterranea | mk4.029848.00 | Carbonic anhydrase-related protein |
Schmidtea mediterranea | mk4.002068.01 | Carbonic anhydrase-related protein |
Schmidtea mediterranea | mk4.021301.01 | Carbonic anhydrase-related protein |
Schmidtea mediterranea | mk4.002068.05 | Carbonic anhydrase-related protein |
Trypanosoma brucei gambiense | Tbg972.11.9430 | carbonic anhydrase-like protein |
Trypanosoma brucei | Tb927.11.8260 | carbonic anhydrase-like protein |
Trypanosoma congolense | TcIL3000.11.8800 | carbonic anhydrase-like protein |
Trypanosoma congolense | TcIL3000_0_06520 | carbonic anhydrase-like protein |
Trypanosoma cruzi | TcCLB.508817.130 | carbonic anhydrase-like protein, putative |
Trypanosoma cruzi | TcCLB.509597.20 | carbonic anhydrase-like protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0290 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0290 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0290 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.0290 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Mus musculus | carbonic anhydrase 7 | Compounds | References |
Stylophora pistillata | Alpha carbonic anhydrase | Compounds | References |
Stylophora pistillata | Carbonic anhydrase | Compounds | References |
Sulfurihydrogenibium sp. (strain YO3AOP1) | Carbonate dehydratase | Compounds | References |
Homo sapiens | carbonic anhydrase II | Compounds | References |
Thiomicrospira crunogena (strain XCL-2) | Carbonic anhydrase, alpha family | Compounds | References |
Drosophila melanogaster | Carbonic anhydrase 2 | Compounds | References |
Bos taurus | Carbonic anhydrase II | Compounds | References |
Homo sapiens | carbonic anhydrase VII | Compounds | References |
Rattus norvegicus | Carbonic anhydrase II | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Astrosclera willeyana | Astrosclerin-3 | 292 aa | 24.3% | 272 aa | Compounds | References |